1. Volume 43, Issue 4, Pages 391-404 (April 2003)
European Psychometric Validation of the CONTILIFE®: A Quality of Life Questionnaire for Urinary Incontinence 
Gérard Amarenco, Benoit Arnould, Paulo Carita, François Haab, Jean-Jacques Labat, François Richard 
European Urology 
Volume 43, Issue 4, Pages (April 2003)
DOI: /S (03)00054-X

2. Fig. 1
Distribution of CONTILIFE® scores for 468 women suffering from genuine stress incontinence according to the number of urinary leaks per week. Patients were split into 4 classes: [0; 7], ]7; 13], ]13; 21] and >21 urinary leaks per week. DA, Daily Activities; EA, Effort Activities; SI, Self-Image; EM, Emotional Consequences; SEX, Sexuality; WLB, Well-Being; Global, Global Index. Lower QoL scores indicated better QoL.
European Urology  , DOI: ( /S (03)00054-X)

3. Fig. 2
Distribution of CONTILIFE® scores for 504 women suffering from genuine stress incontinence according to their age. Patients were split into 4 classes: ≤1st quartile (≤43 years); ]1st quartile, median] (]43; 51] years); ]median, 3rd quartile] (]51; 59] years); and >3rd quartile (>59 years). DA, EA, SI, EM, SEX, WLB and Global: see Fig. 1.
European Urology  , DOI: ( /S (03)00054-X)

4. Fig. 3
Distribution of CONTILIFE® scores for 504 women suffering from genuine stress incontinence according to their menopausal status (yes/no) DA, EA, SI, EM, SEX, WLB and Global: see Fig. 1.
European Urology  , DOI: ( /S (03)00054-X)

5. Fig. 4
Distribution of change in CONTILIFE® scores for 459 women suffering from genuine stress incontinence between baseline and D28 according to change in the number of urinary leaks. Patients were split into 3 classes: improved (decrease of at least 50% in the number of urinary leaks under treatment); minimally improved (decrease between 25% and 50% in the number of urinary leaks), and stable (increase or decrease of less than 25% in the number of urinary leaks). DA, EA, SI, EM, SEX, WLB and Global: see Fig. 1. A decrease in QoL scores indicated an increase in QoL.
European Urology  , DOI: ( /S (03)00054-X)

6. European Urology 2003 43, 391-404DOI: (10.1016/S0302-2838(03)00054-X)

7. European Urology 2003 43, 391-404DOI: (10.1016/S0302-2838(03)00054-X)

8. European Urology 2003 43, 391-404DOI: (10.1016/S0302-2838(03)00054-X)

9. European Urology 2003 43, 391-404DOI: (10.1016/S0302-2838(03)00054-X)

10. European Urology 2003 43, 391-404DOI: (10.1016/S0302-2838(03)00054-X)

11. European Urology 2003 43, 391-404DOI: (10.1016/S0302-2838(03)00054-X)